Metformin was designed to treat type 2 diabetes.Now, Abraham Schneider, DDS, PhD, at @UMSOD is uncovering how this affordable medication could support craniofacial bone regeneration — helping patients heal after oral trauma, surgery, or disease.Supported by the National Institutes of Health, his work represents a potential breakthrough in non-invasive bone repair and oral health innovation.https://umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #NIHResearch #MetforminScience #BoneHealing #DentalInnovation #MedicalResearch #Science #Dentistry #DentalSurgery
More from Youtube
- 0:56Could Weight-Loss Drugs Curb Cravings for Addictive Substances? | Breakthroughs Can’t WaitEveryone has heard of Ozempic and Wegovy for treating diabetes and weight loss. But, what's been discovered in clinical trials, is an anti-craving effect is showing promising results for those battling alcohol and drug addiction.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 0:55Confronting the 4th Wave of the Drug Overdose Death Crisis | Breakthroughs Can't WaitOpioid and cocaine use epidemic is entrenched within Baltimore city, and there are no FDA-approved treatment for any stimulant disorders.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
